The role of nutraceuticals in the prevention of cardiovascular disease
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Cardiovascular disease (CVD) ranks among the most common health-related and economic issues worldwide. Dietary factors are important contributors to cardiovascular risk, either directly, or through their effects on other cardiovascular risk factors including hypertension, dyslipidemia and diabetes mellitus. Nutraceuticals are natural nutritional compounds, which have been shown to be efficacious in preventative medicine or in the treatment of disease. Several foods and dietary supplements have been shown to protect against the development of CVD. The aim of this review is to present an update on the most recent evidence relating to the use of nutraceuticals in the context of the prevention and treatment of CVD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw106 · Cited by 6,457
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
De Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Wang, X., Ouyang, Y., Liu, J., Zhu, M., Zhao, G., Bao, W., & Hu, F. B. (2014) · BMJ · doi:10.1136/bmj.g4490 · Cited by 1,596 · cited 1×
“It has been suggested that consumption of flavonoid-rich fruits and vegetables may lower blood pressure (88).”
Background2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Catapano, A. L., Graham, I., De Backer, G., Wiklund, O., Chapman, M. J., Drexel, H., Hoes, A. W., Jennings, C. S., Landmesser, U., Pedersen, T. R., et al. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.018 · Cited by 1,582
Silverman, M. G., Ference, B. A., Im, K., Wiviott, S. D., Giugliano, R. P., Grundy, S. M., Braunwald, E., & Sabatine, M. S. (2016) · JAMA · doi:10.1001/jama.2016.13985 · Cited by 1,483 · cited 1×
“In particular, low LDL-C levels are associated with lower rates of major coronary events (20).”
BackgroundTea Polyphenols for Health Promotion
Khan, N., & Mukhtar, H. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.06.011 · Cited by 1,156
Diabetes and Decline in Heart Disease Mortality in US Adults
Gu, K. (1999) · JAMA · doi:10.1001/jama.281.14.1291 · Cited by 856 · cited 1×
“Diabetes mellitus type 2 is associated with high risk for developing cardiovascular complications (82).”
BackgroundEffect of ramipril on the incidence of diabetes
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa065061 · Cited by 737 · cited 1×
“Observational studies indicated that diet is one of the factors, which might prevent diabetes and its complications (94).”
BackgroundHooper, L., Kay, C., Abdelhamid, A., Kroon, P. A., Cohn, J. S., Rimm, E. B., & Cassidy, A. (2012) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.023457 · Cited by 610 · cited 2×
“However, no effect upon fasting glucose or HbA1c was observed (51).”
BackgroundGylling, H., Plat, J., Turley, S., Ginsberg, H. N., Ellegård, L., Jessup, W., Jones, P. J., Lütjohann, D., Maerz, W., Masana, L., et al. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.11.043 · Cited by 529
Nutritional and therapeutic potential of spirulina
Khan, Z., Bhadouria, P., & Bisen, P. (2005) · Current Pharmaceutical Biotechnology · doi:10.2174/138920105774370607 · Cited by 524
Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus
Bhatt, J. K., Thomas, S., & Nanjan, M. J. (2012) · Nutrition Research · doi:10.1016/j.nutres.2012.06.003 · Cited by 475 · cited 1×
“A randomized controlled trial revealed that supplementation of resveratrol for 3 months significantly improved the mean hemoglobin A1c, in patients with type 2 diabetes mellitus (39).”
BackgroundThe nutraceutical revolution: its impact on food industry R&D
DeFelice, S. L. (1995) · Trends in Food Science & Technology · doi:10.1016/s0924-2244(00)88944-x · Cited by 468
Hammerstone, J. F., Lazarus, S. A., Mitchell, A. E., Rucker, R., & Schmitz, H. H. (1999) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf980760h · Cited by 455 · cited 1×
“These include catechins, flavonol glycosides, anthocyanins and procyanidins (13).”
BackgroundRas, R. T., Geleijnse, J. M., & Trautwein, E. A. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514000750 · Cited by 379 · cited 2×
“The reduction in plasma LDLC concentrations associated with sterol/stanol consumption may be as large as 10% (26,27).”
BackgroundMethodThe Treatment of Hypertension in Adult Patients With Diabetes
Arauz-Pacheco, C., Parrott, M. A., & Raskin, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.134 · Cited by 326 · cited 1×
“Moreover, patients with diabetes and hypertension have about twice the risk of cardiovascular events as nondiabetic patients with hypertension (83).”
BackgroundRole of Spirulina in the Control of Glycemia and Lipidemia in Type 2 Diabetes Mellitus
Parikh, P., Mani, U., & Iyer, U. (2001) · Journal of Medicinal Food · doi:10.1089/10966200152744463 · Cited by 193 · cited 2×
“SPIRULINA (53) Randomized placebo25 T2DM subjects Spirulina, 2 g/day for 2 months TC, LDL-C reduction, HDLC increase; fasting blood glucose,”
BackgroundGoh, K. P., Lee, H. Y., Lau, D. P., Supaat, W., Chan, Y. H., & Koh, A. F. Y. (2014) · International Journal of Sport Nutrition and Exercise Metabolism · doi:10.1123/ijsnem.2013-0045 · Cited by 187 · cited 1×
“The mechanism of action of resveratrol in the treatment of diabetes mellitus seems to be multifactorial; resveratrol may have antioxidant properties, increase AMPK activation, and increase internalization of glucose through modulating glucose transporter expression (98-100).”
BackgroundTorres-Duran, P. V., Ferreira-Hermosillo, A., & Juarez-Oropeza, M. A. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-33 · Cited by 181
Barona, J., Aristizabal, J. C., Blesso, C. N., Volek, J. S., & Fernandez, M. L. (2012) · The Journal of Nutrition · doi:10.3945/jn.112.162743 · Cited by 173 · cited 2×
“(64) Randomized double blind placebocontrolled crossover 24 males with metabolic syndrome Grape polyphenol powder, 267 mg/day for 30 days SBP reduction; no change in DPB, HDL-C, fasting plasma glucose”
BackgroundMethodA randomized study to establish the effects of spirulina in type 2 diabetes mellitus patients
Lee, E. H., Park, J.-E., Choi, Y.-J., Huh, K.-B., & Kim, W.-Y. (2008) · Nutrition Research and Practice · doi:10.4162/nrp.2008.2.4.295 · Cited by 164
Serban, M.-C., Sahebkar, A., Dragan, S., Stoichescu-Hogea, G., Ursoniu, S., Andrica, F., & Banach, M. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2015.09.007 · Cited by 156 · cited 1×
“A recent meta-analysis of seven randomized controlled trials with Spirulina appeared to confirm these findings (74).”
BackgroundSelf-citationLin, X., Zhang, I., Li, A., Manson, J. E., Sesso, H. D., Wang, L., & Liu, S. (2016) · The Journal of Nutrition · doi:10.3945/jn.116.237644 · Cited by 150 · cited 1×
“The results of a randomized controlled trial also support a role for cocoa flavanol intake in improving insulin resistance (48).”
BackgroundZheng, X.-X., Xu, Y.-L., Li, S.-H., Hui, R., Wu, Y.-J., & Huang, X.-H. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.032573 · Cited by 146 · cited 1×
“Furthermore, a meta-analysis of has also indicated changes in fasting glucose but glycated hemoglobin similar as fasting blood insulin and HOMA-IR did not change after green tea catechins administration (65).”
BackgroundKhalesi, S., Sun, J., Buys, N., Jamshidi, A., Nikbakht-Nasrabadi, E., & Khosravi-Boroujeni, H. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0720-1 · Cited by 138 · cited 1×
“Studies on tea polyphenols have also reported blood pressure lowering properties (58,61).”
BackgroundSmall LDL-Cholesterol is Superior to LDL-Cholesterol for Determining Severe Coronary Atherosclerosis
Koba, S., Yokota, Y., Hirano, T., Ito, Y., Ban, Y., Tsunoda, F., Sato, T., Shoji, M., Suzuki, H., Geshi, E., et al. (2008) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e572 · Cited by 102
Barrios, V., Escobar, C., Cicero, A. F. G., Burke, D., Fasching, P., Banach, M., & Bruckert, E. (2017) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2016.10.003 · Cited by 96 · cited 1×
“A very recent meta-analysis of several randomized controlled trials revealed that this nutraceutical is safe, well tolerated and confirmed the beneficial effects upon lipid profile with reductions in plasma TC of 11–21% and reductions in LDL-C of 15– 31% (69).”
Amir Shaghaghi, M., Abumweis, S. S., & Jones, P. J. H. (2013) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2013.07.006 · Cited by 88
Yarmolinsky, J., Gon, G., & Edwards, P. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv001 · Cited by 80 · cited 1×
“(77) Meta-analysis of 10 trials 834 participants Green tea extract or beverages, 250 – 583 mg/day, duration range: 8 – 14 weeks SBP (MD -2.”
BackgroundLi, Y., Wang, C., Huai, Q., Guo, F., Liu, L., Feng, R., & Sun, C. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2641 · Cited by 80
Ursoniu, S., Sahebkar, A., Serban, M.-C., & Banach, M. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.50960 · Cited by 80
Self-citationHan, S., Jiao, J., Xu, J., Zimmermann, D., Actis-Goretta, L., Guan, L., Zhao, Y., & Qin, L. (2016) · Scientific Reports · doi:10.1038/srep31337 · Cited by 63 · cited 1×
“3 g/d); dose –response relationships (28) Meta-analysis of 15 RCTs 500 patients treated with statins Plant sterols/stanols dose range: 1.”
BackgroundSahebkar, A., Serban, C., Ursoniu, S., & Banach, M. (2016) · Nutrition · doi:10.1016/j.nut.2015.06.009 · Cited by 52
Self-citationO'Keeffe, C., Kabir, Z., O'Flaherty, M., Walton, J., Capewell, S., & Perry, I. J. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-002837 · Cited by 47 · cited 1×
“Reduction of risk factors in the population, especially blood pressure reduction and lipid-lowering can have important impacts upon mortality from CVD (4).”
Background
Cited by
Oppedisano, F., Macrì, R., Gliozzi, M., Musolino, V., Carresi, C., Maiuolo, J., Bosco, F., Nucera, S., Caterina Zito, M., Guarnieri, L., et al. (2020) · Biomedicines · doi:10.3390/biomedicines8090306 · Cited by 323
Charchar, F. J., Prestes, P. R., Mills, C., Ching, S. M., Neupane, D., Marques, F. Z., Sharman, J. E., Vogt, L., Burrell, L. M., Korostovtseva, L., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003563 · Cited by 297
Cicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux047 · Cited by 295
Self-citationCicero, A. F. G., Colletti, A., Bajraktari, G., Descamps, O., Djuric, D. M., Ezhov, M., Fras, Z., Katsiki, N., Langlois, M., Latkovskis, G., et al. (2017) · Archives of Medical Science · doi:10.5114/aoms.2017.69326 · Cited by 281
“No significant differences were detected in the levels of aspartate transaminase (AST), alanine transaminase (ALT), and creatinine in comparison to the control group [140].”
BackgroundSelf-citationThe Role of Nutraceuticals in Statin Intolerant Patients
Banach, M., Patti, A. M., Giglio, R. V., Cicero, A. F. G., Atanasov, A. G., Bajraktari, G., Bruckert, E., Descamps, O., Djuric, D. M., Ezhov, M., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.040 · Cited by 272
Self-citation
Metadata
- Authors
- Sosnowska, B., Penson, P., & Banach, M.
- Venue
- Cardiovascular Diagnosis and Therapy
- Publisher
- AME Publishing Company
- Published
- 2017-04
- Volume
- 67
- Issue
- 1
- Pages
- S21-S31
- ISSN
- 2223-3652 (ISSN-L)
- 2223-3660
- OpenAlex
- W2608699298
- Cited by
- 113
- References
- 36
- FWCI
- 10.13
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.